Clinical Trial Detail

NCT ID NCT02654639
Title Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Georgetown University
Indications

colorectal cancer

Therapies

Bevacizumab + trifluridine/tipiracil hydrochloride

Age Groups: adult

No variant requirements are available.